Cargando…

Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study

OBJECTIVE: Characterize the risk for adverse pregnancy, delivery and neonatal outcomes among different advanced maternal ages (AMA). STUDY DESIGN: We conducted a population-based retrospective cohort study using data from the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample to cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado-Gédéon, Alexandre, Badeghiesh, Ahmad, Baghlaf, Haitham, Dahan, Michael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945696/
https://www.ncbi.nlm.nih.gov/pubmed/36846599
http://dx.doi.org/10.1016/j.eurox.2023.100180
_version_ 1784892191020154880
author Machado-Gédéon, Alexandre
Badeghiesh, Ahmad
Baghlaf, Haitham
Dahan, Michael H.
author_facet Machado-Gédéon, Alexandre
Badeghiesh, Ahmad
Baghlaf, Haitham
Dahan, Michael H.
author_sort Machado-Gédéon, Alexandre
collection PubMed
description OBJECTIVE: Characterize the risk for adverse pregnancy, delivery and neonatal outcomes among different advanced maternal ages (AMA). STUDY DESIGN: We conducted a population-based retrospective cohort study using data from the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample to characterize adverse pregnancy, delivery and neonatal outcomes among different AMA groups. Patients aged 44–45 (n = 19,476), 46–49 (n = 7528) and 50–54 years (n = 1100) were compared to patients aged 38–43 years (n = 499,655). A multivariate logistic regression analysis adjusted for statistically significant confounding variables. RESULTS: With advancing age, rates of chronic hypertension, pregestational diabetes, thyroid disease and multiple gestation increased (p < 0.001). The adjusted risk of hysterectomy and need for blood transfusion substantially increased with advancing age, reaching up to an almost 5-fold (aOR, 4.75, 95 % CI, 2.76–8.19, p < 0.001) and 3-fold (aOR, 3.06, 95 % CI, 2.31–4.05, p < 0.001) increased risk, respectively, in patients aged 50–54 years. The adjusted risk of maternal death increased 4-fold in patients aged 46–49 years (aOR, 4.03, 95 % CI, 1.23–13.17, p = 0.021). Adjusted risks of pregnancy-related hypertensive disorders, including gestational hypertension and preeclampsia, increased by 28–93 % across advancing age groups (p < 0.001). Adjusted neonatal outcomes demonstrated up to a 40 % elevated risk of intrauterine fetal demise in patients aged 46–49 years (aOR, 1.40, 95 % CI, 1.02–1.92, p = 0.04) and a 17 % increased risk of having a small for gestational age neonate in patients aged 44–45 years (aOR, 1.17, 95 % CI, 1.05–1.31, p = 0.004). CONCLUSIONS: Pregnancies at AMA are at increased risk for adverse outcomes, particularly for pregnancy-related hypertensive disorders, hysterectomy, blood transfusion, and maternal and fetal mortality. Although comorbidities associated with AMA influence the risk of complications, AMA was demonstrated to be an independent risk factor for major complications, with its impact varying across ages. This data imparts clinicians with the ability to provide more specific counseling to patients of varied AMA. Older patients seeking to conceive must be counseled regarding these risks in order to make well-informed decisions.
format Online
Article
Text
id pubmed-9945696
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99456962023-02-23 Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study Machado-Gédéon, Alexandre Badeghiesh, Ahmad Baghlaf, Haitham Dahan, Michael H. Eur J Obstet Gynecol Reprod Biol X Obstetrics and Maternal Fetal Medicine OBJECTIVE: Characterize the risk for adverse pregnancy, delivery and neonatal outcomes among different advanced maternal ages (AMA). STUDY DESIGN: We conducted a population-based retrospective cohort study using data from the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample to characterize adverse pregnancy, delivery and neonatal outcomes among different AMA groups. Patients aged 44–45 (n = 19,476), 46–49 (n = 7528) and 50–54 years (n = 1100) were compared to patients aged 38–43 years (n = 499,655). A multivariate logistic regression analysis adjusted for statistically significant confounding variables. RESULTS: With advancing age, rates of chronic hypertension, pregestational diabetes, thyroid disease and multiple gestation increased (p < 0.001). The adjusted risk of hysterectomy and need for blood transfusion substantially increased with advancing age, reaching up to an almost 5-fold (aOR, 4.75, 95 % CI, 2.76–8.19, p < 0.001) and 3-fold (aOR, 3.06, 95 % CI, 2.31–4.05, p < 0.001) increased risk, respectively, in patients aged 50–54 years. The adjusted risk of maternal death increased 4-fold in patients aged 46–49 years (aOR, 4.03, 95 % CI, 1.23–13.17, p = 0.021). Adjusted risks of pregnancy-related hypertensive disorders, including gestational hypertension and preeclampsia, increased by 28–93 % across advancing age groups (p < 0.001). Adjusted neonatal outcomes demonstrated up to a 40 % elevated risk of intrauterine fetal demise in patients aged 46–49 years (aOR, 1.40, 95 % CI, 1.02–1.92, p = 0.04) and a 17 % increased risk of having a small for gestational age neonate in patients aged 44–45 years (aOR, 1.17, 95 % CI, 1.05–1.31, p = 0.004). CONCLUSIONS: Pregnancies at AMA are at increased risk for adverse outcomes, particularly for pregnancy-related hypertensive disorders, hysterectomy, blood transfusion, and maternal and fetal mortality. Although comorbidities associated with AMA influence the risk of complications, AMA was demonstrated to be an independent risk factor for major complications, with its impact varying across ages. This data imparts clinicians with the ability to provide more specific counseling to patients of varied AMA. Older patients seeking to conceive must be counseled regarding these risks in order to make well-informed decisions. Elsevier 2023-02-08 /pmc/articles/PMC9945696/ /pubmed/36846599 http://dx.doi.org/10.1016/j.eurox.2023.100180 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Obstetrics and Maternal Fetal Medicine
Machado-Gédéon, Alexandre
Badeghiesh, Ahmad
Baghlaf, Haitham
Dahan, Michael H.
Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study
title Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study
title_full Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study
title_fullStr Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study
title_full_unstemmed Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study
title_short Adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: A population-based retrospective cohort study
title_sort adverse pregnancy, delivery and neonatal outcomes across different advanced maternal ages: a population-based retrospective cohort study
topic Obstetrics and Maternal Fetal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945696/
https://www.ncbi.nlm.nih.gov/pubmed/36846599
http://dx.doi.org/10.1016/j.eurox.2023.100180
work_keys_str_mv AT machadogedeonalexandre adversepregnancydeliveryandneonataloutcomesacrossdifferentadvancedmaternalagesapopulationbasedretrospectivecohortstudy
AT badeghieshahmad adversepregnancydeliveryandneonataloutcomesacrossdifferentadvancedmaternalagesapopulationbasedretrospectivecohortstudy
AT baghlafhaitham adversepregnancydeliveryandneonataloutcomesacrossdifferentadvancedmaternalagesapopulationbasedretrospectivecohortstudy
AT dahanmichaelh adversepregnancydeliveryandneonataloutcomesacrossdifferentadvancedmaternalagesapopulationbasedretrospectivecohortstudy